These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35996527)

  • 21. Pharmacokinetic and pharmacodynamic studies of nisoldipine-loaded solid lipid nanoparticles developed by central composite design.
    Dudhipala N; Veerabrahma K
    Drug Dev Ind Pharm; 2015; 41(12):1968-77. PubMed ID: 25830370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved uptake and bioavailability of cinnamaldehyde
    Wu L; Meng Y; Xu Y; Chu X
    Pharm Dev Technol; 2022 Dec; 27(10):1038-1048. PubMed ID: 36367964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Chitosan Derivatives Modified Mesoporous Silica Nanoparticles as Delivery Carrier.
    Li Q; Wang W; Hu G; Cui X; Sun D; Jin Z; Zhao K
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33923304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chitosan-Coated Solid Lipid Nanoparticles as an Efficient Avenue for Boosted Biological Activities of
    Aldayel TS; M Badran M; H Alomrani A; AlFaris NA; Z Altamimi J; S Alqahtani A; A Nasr F; Ghaffar S; Orfali R
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110803
    [No Abstract]   [Full Text] [Related]  

  • 25. Raloxifene-loaded SLNs with enhanced biopharmaceutical potential: QbD-steered development, in vitro evaluation, in vivo pharmacokinetics, and IVIVC.
    Jain A; Sharma T; Kumar R; Katare OP; Singh B
    Drug Deliv Transl Res; 2022 May; 12(5):1136-1160. PubMed ID: 33966178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fexofenadine-loaded chitosan coated solid lipid nanoparticles (SLNs): A potential oral therapy for ulcerative colitis.
    El-Dakroury WA; Zewail MB; Asaad GF; Abdallah HMI; Shabana ME; Said AR; Doghish AS; Azab HA; Amer DH; Hassan AE; Sayed AS; Samra GM; Sallam AM
    Eur J Pharm Biopharm; 2024 Mar; 196():114205. PubMed ID: 38311187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancing Mucosal Immune Response of Newcastle Disease Virus DNA Vaccine Using N-2-Hydroxypropyl Trimethylammonium Chloride Chitosan and N,O-Carboxymethyl Chitosan Nanoparticles as Delivery Carrier.
    Zhao K; Han J; Zhang Y; Wei L; Yu S; Wang X; Jin Z; Wang Y
    Mol Pharm; 2018 Jan; 15(1):226-237. PubMed ID: 29172532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation and Pathohistological Study of Mizolastine-Solid Lipid Nanoparticles-Loaded Ocular Hydrogels.
    El-Emam GA; Girgis GNS; Hamed MF; El-Azeem Soliman OA; Abd El Gawad AEGH
    Int J Nanomedicine; 2021; 16():7775-7799. PubMed ID: 34853513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced oral delivery of curcumin from N-trimethyl chitosan surface-modified solid lipid nanoparticles: pharmacokinetic and brain distribution evaluations.
    Ramalingam P; Ko YT
    Pharm Res; 2015 Feb; 32(2):389-402. PubMed ID: 25082210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orally delivered solid lipid nanoparticles of irinotecan coupled with chitosan surface modification to treat colon cancer: Preparation, in-vitro and in-vivo evaluations.
    Bhaskaran NA; Jitta SR; Salwa ; Cheruku S; Kumar N; Kumar L
    Int J Biol Macromol; 2022 Jun; 211():301-315. PubMed ID: 35568152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.
    Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F
    AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and testing of quaternized chitosan nanoparticles as gene delivery vehicles.
    Li GF; Wang JC; Feng XM; Liu ZD; Jiang CY; Yang JD
    Appl Biochem Biotechnol; 2015 Apr; 175(7):3244-57. PubMed ID: 25686559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
    Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
    Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solid lipid nanoparticles with enteric coating for improving stability, palatability, and oral bioavailability of enrofloxacin.
    Li C; Zhou K; Chen D; Xu W; Tao Y; Pan Y; Meng K; Shabbir MAB; Liu Q; Huang L; Xie S
    Int J Nanomedicine; 2019; 14():1619-1631. PubMed ID: 30880969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Eur J Pharm Biopharm; 2017 Jan; 110():47-57. PubMed ID: 27810472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid nanoparticles coated with chitosan using a one-step association method to target rifampicin to alveolar macrophages.
    Vieira ACC; Chaves LL; Pinheiro M; Lima SC; Neto PJR; Ferreira D; Sarmento B; Reis S
    Carbohydr Polym; 2021 Jan; 252():116978. PubMed ID: 33183580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and characterization of nanostructured lipid carriers based chitosan thermosensitive hydrogel for delivery of dexamethasone.
    Tan G; Yu S; Li J; Pan W
    Int J Biol Macromol; 2017 Oct; 103():941-947. PubMed ID: 28545971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mannose-anchored quaternized chitosan/thiolated carboxymethyl chitosan composite NPs as mucoadhesive carrier for drug delivery.
    Jin Z; Hu G; Zhao K
    Carbohydr Polym; 2022 May; 283():119174. PubMed ID: 35153010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. pH-sensitive dual drug loaded janus nanoparticles by oral delivery for multimodal analgesia.
    Liu L; Yao W; Xie X; Gao J; Lu X
    J Nanobiotechnology; 2021 Aug; 19(1):235. PubMed ID: 34362394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, characterization and in vivo performance of solid lipid nanoparticles (SLNs)-loaded mucoadhesive buccal tablets for efficient delivery of Lornoxicam in experimental inflammation.
    Zewail MB; F Asaad G; Swellam SM; Abd-Allah SM; K Hosny S; Sallah SK; E Eissa J; S Mohamed S; El-Dakroury WA
    Int J Pharm; 2022 Aug; 624():122006. PubMed ID: 35820515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.